Back to search

Article

Harnessing the Transcriptional Signatures of Car-T Cells and Leukemia/Lymphoma Using Single-Cell Sequencing Technologies

2024-01-05

Abstract excerpt

Chimeric antigen receptor (CAR) T-cell therapy has greatly improved outcomes for patients with relapsed or refractory hematological malignancies. However, challenges such as treatment resistance, relapse, and severe toxicity still hinder its widespread clinical application. Traditional transcriptome analysis has provided limited insights into the complex transcriptional landscape of both leukemia cells and enginee...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8fc68294-11ed-5f38-b4e6-ccf5ec3d8e42
DOI
10.20944/preprints202401.0451.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Harnessing the Transcriptional Signatures of Car-T Cells and Leukemia/Lymphoma Using Single-Cell Sequencing TechnologiesDOI 10.20944/preprints202401.0451.v1
Select a neighboring publication to make it the new centre.